TotalMarketCap

Kura Oncology

KURANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$606.267 M

$6.82 -10.45%

Close of 6 Nov 2026

As of 6 Nov 2026, Kura Oncology (KURA) has a market capitalization of $606.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$67.5M

#2618 by revenue

Earnings

-$278.7M

Loss-making

Shares outstanding

88,960,619

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #174GeronGERN$612.0M
  2. #175Nuvectis PharmaNVCT$610.7M
  3. #176Kura OncologyKURA$606.3M
  4. #177ArriVent BioPharmaAVBP$602.5M
  5. #178Immix BiopharmaIMMX$597.3M

What if Kura Oncology were worth as much as…

Open the what-if tool →

Gold $28.2T

$317,408.69

Per share 46,575× higher

Bitcoin $1.53T

$17,174.43

Per share 2,520× higher

Apple $5.02T

$56,382.06

Per share 8,273× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Kura Oncology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.